These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 998139)

  • 21. Isolation and characterization of human Factor VIII (antihemophilic factor).
    Legaz ME; Schmer G; Counts RB; Davie EW
    J Biol Chem; 1973 Jun; 248(11):3946-55. PubMed ID: 4708094
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methods of preparing Factor VIII. I. Preparation and characteristics of a medium-pure concentrate].
    Perote P; Altamirano P; Aperador R; Camacho Y; Acosta J
    Sangre (Barc); 1984; 29(3):321-8. PubMed ID: 6435268
    [No Abstract]   [Full Text] [Related]  

  • 23. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
    Austen DE; Smith JK
    Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separation of human antihemophilic factor (AHF, factor VIII) from fibrinogen by means of defibrase.
    Lopaciuk S; Latallo ZS; Bykowska K; Daszynski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(6):671-8. PubMed ID: 54318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
    Harris RB; Newman J; Johnson AJ
    Biochim Biophys Acta; 1981 May; 668(3):456-70. PubMed ID: 6786356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on purification of human factor VIII, HMW and LMW subunits and on properties of rabbit antibodies (author's transl)].
    Aihara M; Sawada Y; Segawa M; Kimura A; Chiba Y; Yoshida Y
    Rinsho Ketsueki; 1980 Jan; 21(1):24-32. PubMed ID: 6768912
    [No Abstract]   [Full Text] [Related]  

  • 29. Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
    Biochim Biophys Acta; 1986 Oct; 873(3):356-66. PubMed ID: 3092864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homo- and heterogeneous forms of human factor VIII.
    Vukovich TC
    Thromb Haemost; 1982 Aug; 48(1):98-100. PubMed ID: 6814000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electrophoretic studies of human plasma cryoprecipitates with a high content of antihemophilic globulin A].
    Kleint V; Wegner H
    Z Gesamte Inn Med; 1970 Apr; 25(7):312-4. PubMed ID: 5521442
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of rabbit anti-human fibrinogen antibodies cross reactivity of mammalian fibrinogen.
    Burstein M; Legmann P
    Nouv Rev Fr Hematol (1978); 1976; 16(3):345-56. PubMed ID: 827734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment of estradiol receptor from calf uterus.
    Dietrich W; Wand H; Helbing D; Görlich M
    Folia Biol (Praha); 1993; 39(1):58-61. PubMed ID: 8348987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: comparative protein chemical studies].
    Liebe S; Kubel M; Wegner H
    Z Gesamte Inn Med; 1974 Mar; 29(6):232-6. PubMed ID: 4409089
    [No Abstract]   [Full Text] [Related]  

  • 38. Affinity chromatography of human factor VIII using human and rabbit antibodies to Factor VIII.
    Lane JL; Ekert H; Vafiadis A
    Thromb Haemost; 1979 Dec; 42(4):1306-15. PubMed ID: 120620
    [No Abstract]   [Full Text] [Related]  

  • 39. Purification and properties of porcine platelet aggregating factor.
    Marcus DL; Johnson AJ; Finlay TH
    Biochim Biophys Acta; 1978 Nov; 537(1):44-61. PubMed ID: 718981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies.
    Rotblat F; O'Brien DP; O'Brien FJ; Goodall AH; Tuddenham EG
    Biochemistry; 1985 Jul; 24(16):4294-300. PubMed ID: 2413885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.